Categories AlphaGraphs, Earnings, Health Care
Biogen (BIIB) Q3 2023 Earnings: Key financials and quarterly highlights
Biogen Inc. (NASDAQ: BIIB) reported third quarter 2023 earnings results today.
Total revenue rose 1% year-over-year to $2.53 billion. Revenues grew 3% in constant currency.
Net loss attributable to Biogen Inc. was $68.1 million, or $0.47 per share, compared to income of $1.13 billion, or $7.84 per share, last year. Adjusted EPS decreased 9% to $4.36.
The company expects a low single digit percentage decline in total revenue for the full year of 2023 compared to the previous year. Adjusted EPS is expected to be $14.50-15.00.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
GIS Earnings: All you need to know about General Mills’ Q2 2025 earnings results
General Mills, Inc. (NYSE: GIS) reported its second quarter 2025 earnings results today. Net sales increased 2% year-over-year to $5.2 billion. Organic sales were up 1%. Net earnings attributable to
Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025
For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model
Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third
